Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning

Journal of Nutrition

Volumn 138, Issue 10, 2008, Pages 1902-1909

  Abdukeyum, Grace G ^a   Owen, Alice J ^a,b   McLennan, Peter L ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; OLIVE OIL; POLYUNSATURATED FATTY ACID; SUNFLOWER OIL;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

HELIANTHUS; RATTUS; RATTUS NORVEGICUS; SCOMBRIDAE;

EID: 54749084290     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/138.10.1902     Document Type: Article

References (55)

1. Valagussa F, Franzosi MG, Geraci E, Mininni N, Nicolosi GL, Santini M, Tavazzi L, Vecchio C, Marchioli R, et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447-55.
2. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-9.
3. Burr ML, Fehily AM, Gilbert JF. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757-61.
4. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-8.
5. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897-903.
6. McLennan PL, Abeywardena MY, Charnock JS. Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J. 1988;116:709-17.
7. Pepe S, McLennan PL. Dietary fish oil confers direct antiarrhythmic properties on the myocardium of rats. J Nutr. 1996;126:34-42.
8. Pepe S, McLennan PL. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation. 2002;105:2303-8.
9. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-36.
10. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev. 2003;83:1113-51.
11. Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation. 1991;84:341-9.
12. Hagar JM, Hale SL, Kloner RA. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ Res. 1991;68:61-8.
13. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol. 1987;253:H1470-6.
14. Tanoue Y, Herijgers P, Meuris B, Verbeken E, Leunens V, Lox M, Flameng W. Ischemic preconditioning reduces unloaded myocardial oxygen consumption in an in-vivo sheep model. Cardiovasc Res. 2002;55:633-41.
15. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol. 2000;62:79-109.
16. Szekeres L. Drug-induced delayed cardiac protection against the effects of myocardial ischemia. Pharmacol Ther. 2005;108:269-80.
17. Kloner RA, Rezkalla SH. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res. 2006;70:297-307.
18. Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr. 1997;127:S838-41.
19. Owen AJ, Peter-Przyborowska BA, Hoy AJ, McLennan PL. Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition. Lipids. 2004;39:955-61.
20. National Health and Medical Research Council. Australian code of practice for the care and use of animals for scientific purposes. 7th ed. Canberra (Australia): National Health and Medical Research Council; 2004. p. 84
21. McLennan PL, Bridle TM, Abeywardena MY, Charnock JS. Comparative efficacy of n-3 and n-6 polyunsaturated fatty acids in modulating ventricular fibrillation threshold in marmoset monkeys. Am J Clin Nutr. 1993;58:666-9.
22. Pepe S, Mclennan PL. (n-3) long chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats. J Nutr. 2007;137:2377-83.
23. Zhu BQ, Sievers RE, Sun YP, Morse-Fisher N, Parmley WW, Wolfe CL. Is the reduction of myocardial infarct size by dietary fish oil the result of altered platelet function? Am Heart J. 1994;127:744-55.
24. McGuinness J, Neilan TG, Sharkasi A, Bouchier-Hayes D, Redmond JM. Myocardial protection using an omega-3 fatty acid infusion: quantification and mechanism of action. J Thorac Cardiovasc Surg. 2006;132:72-9.
25. Landmark K, Abdelnoor M, Urdal P, Kilhovd B, Dorum HP, Borge N, Refvem H. Use of fish oils appears to reduce infarct size as estimated from peak creatine kinase and lactate dehydrogenase activities. Cardiology. 1998;89:94-102.
26. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol. 1992;263:H1107-12.
27. Al Makdessi S, Brandle M, Ehrt M, Sweidan H, Jacob R. Myocardial protection by ischemic preconditioning: the influence of the composition of myocardial phospholipids. Mol Cell Biochem. 1995;145:69-73.
28. Zhu J, Ferrier GR. Ischemic preconditioning: antiarrhythmic effects and electrophysiological mechanisms in isolated ventricle. Am J Physiol. 1998;274:H66-75.
29. Pepe S, Tsuchiya N, Lakatta EG, Hansford RG. PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH. Am J Physiol. 1999;276:H149-58.
30. Monnet X, Ghaleh B, Lucats L, Colin P, Zini R, Hittinger L, Berdeaux A. Phenotypic adaptation of the late preconditioned heart: myocardial oxygen consumption is reduced. Cardiovasc Res. 2006;70:391-8.
31. Gao WD, Atar D, Backx PH, Marban E. Relationship between intracellular calcium and contractile force in stunned myocardium. Direct evidence for decreased myofilament Ca2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ Res. 1995;76:1036-48.
32. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation. 2005;112:1945-52.
33. Jouven X, Zureik M, Desnos M, Guerot C, Ducimetiere P. Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res. 2001;50:373-8.
34. McLennan PL, Abeywardena MY. Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death. J Membr Biol. 2005;206:85-102.
35. Zaloga GP, Ruzmetov N, Harvey KA, Terry C, Patel N, Stillwell W, Siddiqui R. (n-3) Long-chain polyunsaturated fatty acids prolong survival following myocardial infarction in rats. J Nutr. 2006;136:1874-8.
36. Matthan NR, Jordan H, Chung M, Lichtenstein AH, Lathrop DA, Lau J. A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models. Metabolism. 2005;54:1557-65.
37. Harris WS, Gonzales M, Laney N, Sastre A, Borkon AM. Effects of omega-3 fatty acids on heart rate in cardiac transplant recipients. Am J Cardiol. 2006;98:1393-5.
38. Tuna oil [Alphabetical Listing of GRAS Notices]. U.S. FDA Center for Food Safety and Applied Nutrition, Office of Food Additive Safety; c2002 [cited 2008 July 2]. Available from: http://www.cfsan.fda.gov/;rdb/opa-g109.html
39. Bays H. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Am J Cardiol. 2006;98:i71-6.
40. USDA National Nutrient Database for Standard Reference. Release 20. [homepageon the Internet]. USDA, Agricultural Research Service; c2007 [cited 2008 July 1]. Available from: http://www.ars.usda.gov/ba/bhnrc/ndl
41. Psota TL, Gebauer SK, Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol. 2006;98:i3-18.
42. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao G, Etherton TD. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 2000;71 Suppl:S179-88.
43. Amiano P, Dorronsoro M, de Renobales M, Ruiz de Gordoa JC, Irigoien I, Spain EGo. Very-long-chain omega-3 fatty acids as markers for habitual fish intake in a population consuming mainly lean fish: the EPIC cohort of Gipuzkoa. European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr. 2001;55:827-32.
44. Charnock JS, Abeywardena MY, McLennan PL. Comparative changes in the fatty-acid composition of rat cardiac phospholipids after long-term feeding of sunflower seed oil- or tuna fish oil-supplemented diets. Ann Nutr Metab. 1986;30:393-406.
45. Charnock JS, Abeywardena MY, Poletti VM, McLennan PL. Differences in fatty acid composition of various tissues of the marmoset monkey (Callithrix jacchus) after different lipid supplemented diets. Comp Biochem Physiol Comp Physiol. 1992;101:387-93.
46. McLennan P, Howe P, Abeywardena M, Muggli R, Raederstorff D, Mano M, Rayner T, Head R. The cardiovascular protective role of docosahexaenoic acid. Eur J Pharmacol. 1996;300:83-9.
47. Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation. 2004;110:1645-9.
48. Grimsgaard S, Bonaa KH, Hansen JB, Myhre ES. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr. 1998;68:52-9.
49. Cunnane SC, Anderson MJ. The majority of dietary linoleate in growing rats is beta-oxidized or stored in visceral fat. J Nutr. 1997;127:146-52.
50. Cunnane SC, Anderson MJ. Pure linoleate deficiency in the rat: Influence on growth, accumulation of n-6 polyunsaturates, and [1-C-14]linoleate oxidation. J Lipid Res. 1997;38:805-12.
51. McLennan PL, Bridle TM, Abeywardena MY, Charnock JS. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J. 1992;123:1555-61.
52. Alphabetical Listing of GRAS Notices. U.S. FDA Centre for Food Safety and Applied Nutrition, Office of Food Additive Safety; c2008 [cited 2008 July 2]. Available from: http://www.cfsan.fda.gov/~rdb/opagras1.html
53. Cohen MV, Yang X-M, Liu GS, Heusch G, Downey JM. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial KATP channels. Circ Res. 2001;89:273-8.
54. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747-57.
55. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, Jordan HS, Lau J. n-3 Fatty acids from fish or fish-oil supplements, but not {alpha}-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84:5-17.